Oct 2023 DOI 10.14302/issn.3070-2313.jeh-23-4547
Millions of women use hormonal contraceptive pills around the world and though the physical effects are thoroughly described in the literature and clinical setting. The psychological effects have been largely ignored until recently. Recent studies have found that the use of hormonal contraceptives has an effect on women’s hormones and psychological well-being. The aim of this present research was to check the effect of hormonal contraceptive pills on anterior pituitary gland among female wister rat histomorphometrically. Thirty (30) female wister rats of 3 month old weighing 150 – 200g were used for the study. They were divided into three (3) groups of 10 rats each. Group one (1) received Microlut Levonorgestrel 30mg at a dose of 0.18g/kg while group two (2) received a combination of microgynon levonorgesrel 150mg and ehinylestadiol 130mg at a dose of o.18g/kg in 5 days cycle while group three (3) serve as control group. The experiment last for 72 days. Histomorphometrical analysis of anterior pituitary gland was carried out. The findings revealed that combined oral contraceptive pills adversely cause the decrease in the cells of the anterior pituitary more than the progestin only pills.
Jul 2016 DOI 10.14302/issn.2381-862X.jwrh-15-806
Background and Objectives: The prevalence of abnormal cervical cytology in morbidly obese women using ThinPrep® liquid-based Pap Test™ and HPV DNA Test™ is unknown. We aimed to investigate whether women with morbid obesity have a higher frequency of abnormal Pap smears compared with nonobese women, and to explore the rate of Pap smear screening in morbidly obese women. Design and Setting: We conducted a retrospective study over five years in two general government hospitals in Dubai. Patients and Methods: We screened ThinPrep slides and HPV DNA of morbidly obese women and nonobese women. The age, ethnicity, demographic and socioeconomic backgrounds of the two groups were matched. We studied hypertension (HTN), diabetes (DM), infertility, sexually transmitted diseases (STD), connective tissue disease (CTD), immunosuppression and oral contraceptive pills (OCP) as potential risk cofactors. Results: Only 90 (29%) out of 310 morbidly obese women had had Pap tests. They showed more prevalence (P<0.05) of ASC-US, high-risk HPV DNA and LSIL 16 positive (18%) (95% CI: 7.0, and of endometrial AGCs {4 positive (4.5%) (95% CI: 0.3-13.5)} than the nonobese women (n=8175), {279 positive (3%) (95% CI: 3.0-3.8} , and {2 positive (0.024%) (CI:0.01-0.09)}. There were no endocervical AGCs, HSIL or squamous cancer in morbidly obese women. DM, HTN, OCPs, CTD and STD were more common in morbidly obese women having abnormal Pap smears. Conclusions: Low-grade squamous abnormalities, high-risk HPV, and endometrial AGCs are more frequent in morbidly obese women than in nonobese women. Women with morbid obesity have a low rate of cervical screening. This, among other factors, could increase the risk of these women to abnormal cervical cytology. This vulnerable group should benefit from more frequent cervical cytology screening. Appropriate clinical and educational measures should be implemented to encourage compliance to Pap smears. Weight reduction might help.